Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients

Neurobiology of Aging

Volumn 30, Issue 2, 2009, Pages 198-209

  Ojala, Johanna ^a   Alafuzoff, Irina ^a,b   Herukka, Sanna Kaisa ^a   van Groen, Thomas ^a,c   Tanila, Heikki ^a   Pirttilä, Tuula ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Alzheimer's disease; APP(Swe PS(A246E) mouse; Caspase 1; Cytokine; Inflammation; Interleukin 18; SAMP8

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 8; RNA; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN REGION; CEREBROSPINAL FLUID; CONTROLLED STUDY; FRONTAL LOBE; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ALZHEIMER DISEASE; BRAIN; CASPASE 1; CYTOKINES; HUMANS; INTERLEUKIN-18; UP-REGULATION;

EID: 57849144282     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.06.006     Document Type: Article

References (48)

1. Andre R., Wheeler R.D., Collins P.D., Luheshi G.N., Pickering-Brown S., Kimber I., Rothwell N.J., and Pinteaux E. Identification of a truncated IL-18R beta mRNA: a putative regulator of IL-18 expressed in rat brain. J. Neuroimmunol. 145 1-2 (2003) 40-45
2. Attems J. Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms. Acta Neuropathol. 110 4 (2005) 345-359
3. Bauer J., Strauss S., Volk B., and Berger M. IL-6-mediated events in Alzheimer's disease pathology. Immunol. Today 12 11 (1991) 422
4. Blasko I., Veerhuis R., Stampfer-Kountchev M., Surwein-Teissl M., Eikelenboom P., and Grubeck-Loebenstein B. Co-stimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes. Neurobiol. Dis. 7 6 Pt B (2000) 682-689
5. Borchelt D.R., Ratovitski T., van Lare J., Lee M.K., Gonzales V., Jenkins N.A., Copeland N.G., Price D.L., and Sisodia S.S. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19 4 (1997) 939-945
6. Braak H., and Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82 4 (1991) 239-259
7. Cacabelos R., Alvarez X.A., Fernandez-Novoa L., Franco A., Mangues R., Pellicer A., and Nishimura T. Brain interleukin-1 beta in Alzheimer's disease and vascular dementia. Methods Find Exp. Clin. Pharmacol. 16 2 (1994) 141-151
8. Cannella B., and Raine C.S. Multiple sclerosis: cytokine receptors on oligodendrocytes predict innate regulation. Ann. Neurol. 55 1 (2004) 46-57
9. Chandrasekar B., Mummidi S., Claycomb W.C., Mestril R., and Nemer M. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes. J. Biol. Chem. 280 6 (2005) 4553-4567
10. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 1 (1987) 156-159
11. Conti B., Park L.C., Calingasan N.Y., Kim Y., Kim H., Bae Y., Gibson G.E., and Joh T.H. Cultures of astrocytes and microglia express interleukin 18. Brain Res. Mol. Brain Res. 67 1 (1999) 46-52
12. Curran B., and O'Connor J.J. The pro-inflammatory cytokine interleukin-18 impairs long-term potentiation and NMDA receptor-mediated transmission in the rat hippocampus in vitro. Neuroscience 108 11 (2001) 83-90
13. Desjardins P., and Ledoux S. Expression of ced-3 and ced-9 homologs in Alzheimer's disease cerebral cortex. Neurosci. Lett. 244 2 (1998) 69-72
14. Di Rosa M., Dell'Ombra N., Zambito A.M., Malaguarnera M., Nicoletti F., and Malaguarnera L. Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia. Eur. J. Neurosci. 23 (2006) 2648-2656
15. Fantuzzi G., Reed D.A., Qi M., Scully S., Dinarello C.A., and Senaldi G. Role of interferon regulatory factor-1 in the regulation of IL-18 production and activity. Eur. J. Immunol. 31 2 (2001) 369-375
16. Gerdes N., Sukhova G.K., Libby P., Reynolds R.S., Young J.L., and Schonbeck U. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J. Exp. Med. 195 2 (2002) 245-257
17. Gillespie M.T., and Horwood N.J. Interleukin-18: perspectives on the newest interleukin. Cytokine Growth Factor Rev. 9 2 (1998) 109-116
18. Gomez-Isla T., Hollister R., West H., Mui S., Growdon J.H., Petersen R.C., Parisi J.E., and Hyman B.T. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 41 1 (1997) 17-24
19. Griffin W.S., Sheng J.G., Royston M.C., Gentleman S.M., McKenzie J.E., Graham D.I., Roberts G.W., and Mrak R.E. Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol. 8 1 (1998) 65-72
20. Hampel H., Teipel S.J., Padberg F., Haslinger A., Riemenschneider M., Schwarz M.J., Kotter H.U., Scheloske M., Buch K., Stubner S., Dukoff R., Lasser R., Muller N., Sunderland T., Rapoport S.I., and Moller H.J. Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease. Brain Res. 823 1-2 (1999) 104-112
21. Herzig M.C., Winkler D.T., Burgermeister P., Pfeifer M., Kohler E., Schmidt S.D., Danner S., Abramowski D., Sturchler-Pierrat C., Burki K., van Duinen S.G., Maat-Schieman M.L., Staufenbiel M., Mathews P.M., and Tucker M. Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat. Neurosci. 7 9 (2004) 954-960
22. Joosten L.A., Radstake T.R., Lubberts E., van den Bersselaar L.A., van Riel P.L., van Lent P.L., Barrera P., and van den Berg W.B. Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 48 2 (2003) 339-347
23. Karni A., Koldzic D.N., Bharanidharan P., Khoury S.J., and Weiner H.L. IL-18 is linked to raised IFN-gamma in multiple sclerosis and is induced by activated CD4(+) T cells via CD40-CD40 ligand interactions. J. Neuroimmunol. 125 1-2 (2002) 134-140
24. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Arch. Neurol. 42 11 (1985) 1097-1105
25. Kim Y.-M., Im J.Y., Han S.H., Kang H.S., and Choi I. IFN-γ up-regulates IL-18 gene expression via IFN consensus sequence-binding protein and activator protein-1 elements in macrophages. J. Immunol. 165 6 (2000) 3198-3205
26. Liao Y.-F., Wang B.-J., Cheng H.-T., Kuo L.-H., and Wolfe M.S. Tumor necrosis factor-α, interleukin-1β, and interferon-γ simulate γ-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway. J. Biol. Chem. 279 47 (2004) 49523-49532
27. Lindberg C., Chromek M., Ahrengart L., Brauner A., Schultzberg M., and Garlind A. Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease. Neurochem. Int. 46 7 (2005) 551-557
28. Lu Q., and Wood J.G. Functional studies of Alzheimer's disease tau protein. J. Neurosci. 13 2 (1993) 508-515
29. Martikainen P., Louhelainen A.-M., Kauppinen T., and Alafuzoff I. Human brain tissue microarrays as a platform to investigate diseases of the nervous system. Brain Res. 1089 1 (2006) 33-43
30. Mattson M.P., and Rydel R.E. Amyloid ox-tox transducers. Nature 382 6593 (1996) 674-675
31. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 7 (1984) 939-944
32. Mehlhorn G., Hollborn M., and Schliebs R. Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology. Int. J. Dev. Neurosci. 18 4-5 (2000) 423-431
33. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., and Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 4 (1991) 479-486
34. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K., Akita K., Namba M., Tanabe F., Konishi K., Fukuda S., and Kurimoto M. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378 6552 (1995) 88-91
35. Olney J.W., Wozniak D.F., and Farber N.B. Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies. Arch. Neurol. 54 10 (1997) 1234-1240
36. Pompl P.N., Yemul S., Xiang Z., Ho L., Haroutunian V., Purohit D., Mohs R., and Pasinetti G.M. Caspase gene expression in the brain as a function of the clinical progression of Alzheimer disease. Arch. Neurol. 60 3 (2003) 369-376
37. Puoliväli J., Wang J., Heikkinen T., Heikkilä M., Tapiola T., van Groen T., and Tanila H. Hippocampal Abeta42 levels correlate with spatial memory deficit in APP and PS1 double transgenic mice. Neurobiol. Dis. 9 3 (2002) 339-347
38. Sugama S., Cho B.P., Baker H., Joh T.H., Lucero J., and Conti B. Neurons of the superior nucleus of the medial habenula and ependymal cells express IL-18 in rat CNS. Brain Res. 958 1 (2002) 1-9
39. Suo Z., Tan J., Placzek A., Crawford F., Fang C., and Mullan M. Alzheimer's beta-amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40. Brain Res. 807 1-2 (1998) 110-117
40. Takeda T., Higuchi K., and Hosokawa M. Senescence-accelerated mouse (SAM): with special reference to development and pathological phenotypes. ILAR J. 38 3 (1997) 109-118
41. Takeda T., Hosokawa M., Takeshita S., Irino M., Higuchi K., Matsushita T., Tomita Y., Yasuhira K., Hamamoto H., Shimizu K., Ishii M., and Yamamuro T. A new murine model of accelerated senescence. Mech. Ageing Dev. 17 2 (1981) 183-194
42. Tha K.K., Okuma Y., Miyazaki H., Murayama T., Uehara T., Hatakeyama R., Hayashi Y., and Nomura Y. Changes in expressions of proinflammatory cytokines IL-1beta, TNF-alpha and IL-6 in the brain of senescence accelerated mouse (SAM) P8. Brain Res. 885 1 (2000) 25-31
43. Thomassen E., Bird T.A., Renshaw B.R., Kennedy M.K., and Sims J.E. Binding of interleukin-18 to the interleukin-1 receptor homologous receptor IL-1Rrp1 leads to activation of signaling pathways similar to those used by interleukin-1. J. Interferon Cytokine Res. 18 12 (1998) 1077-1088
44. Tsukamoto K., Watanabe T., Matsushima T., Kinoshita M., Kato H., Hashimoto Y., Kurokawa K., and Teramoto T. Determination by PCR-RFLP of apoE genotype in a Japanese population. J. Lab. Clin. Med. 121 (1993) 598-602
45. Vandenabeele P., and Fiers W. Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain?. Immunol. Today 12 7 (1991) 217-219
46. Woldbaek P.R., Sande J.B., Stromme T.A., Lunde P.K., Djurovic S., Lyberg T., Christensen G., and Tonnessen T. Daily administration of interleukin-18 causes myocardial dysfunction in healthy mice. Am. J. Physiol. Heart Circ. Physiol. 289 2 (2005) H708-H714
47. Yatsiv I., Morganti-Kossmann M.C., Perez D., Dinarello C.A., Novick D., Rubinstein M., Otto V.I., Rancan M., Kossman T., Redaelli C.A., Trentz O., Shohami E., and Stahel P.F. Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury. J. Cereb. Blood Flow Metab. 22 8 (2002) 971-978
48. Zhu S.G., Sheng J.G., Jones R.A., Brewer M.M., Zhou X.Q., Mrak R.E., and Griffin W.S. Increased interleukin-1beta converting enzyme expression and activity in Alzheimer disease. J. Neuropathol. Exp. Neurol. 58 6 (1999) 582-587